Target Selection; Exclusivity Clause Samples

Target Selection; Exclusivity. For any Target that Genentech shall select from the Gene Database, Genentech shall, as soon as reasonably practicable, notify Magainin of Genentech's desire to designate such Target for its own use, exclusive or subject to Third Party rights, as the case may be at the time of designation. Immediately upon designation, Genentech will be deemed to have been granted, at its sole choice, an exclusive fully sublicensable right and license to research, develop, manufacture, make, have made, use, import, export, sell, offer for sale, or have sold Target Compounds and/or Target Products in the Field in the Territory. Notwithstanding the provision of exclusivity in the foregoing sentence, ________________________________________________________________________________ ** Certain portions of this exhibit have been omitted based upon a request for confidential treatment that has been filed with the Commission. The omitted portions have been filed separately with the Commission. and only with respect to designations by Genentech occurring after the Period of Exclusivity ends, the exclusive license granted above shall be subject to Third Party rights only to the extent existing, or subject to Magainin's rights as provided above in Section 3.1.2 in the event that Magainin is involved in an Internal Development Effort with such Target, as defined in Section 3.2(a), as of the time of designation by Genentech.
Target Selection; Exclusivity. (a) Section 3.1.3 of the License Agreement is hereby deleted in its entirety and replaced with the following
Target Selection; Exclusivity 

Related to Target Selection; Exclusivity

  • Non-Exclusivity The services of the Adviser to the Manager, the Allocated Portion and the Trust are not to be deemed to be exclusive, and the Adviser shall be free to render investment advisory or other services to others and to engage in other activities. It is understood and agreed that the directors, officers, and employees of the Adviser are not prohibited from engaging in any other business activity or from rendering services to any other person, or from serving as partners, officers, directors, trustees, or employees of any other firm or corporation.

  • Non-exclusivity, Etc The rights of Indemnitee hereunder will be in addition to any other rights Indemnitee may have under the Charter, the Bylaws or the Maryland General Corporation Law (the "MGCL") or otherwise; provided, however, that to the extent that Indemnitee otherwise would have any greater right to indemnification under any provision of the Charter or Bylaws as in effect on the date hereof, Indemnitee will be deemed to have such greater right hereunder, and provided, further, that to the extent that any change is made to the MGCL (whether by legislative action or judicial decision), the Charter and/or the Bylaws which permits any greater right to indemnification than that provided under this Agreement as of the date hereof, Indemnitee will be deemed to have such greater right hereunder. The Company will not adopt any amendment to the Charter or the Bylaws the effect of which would be to deny, diminish or encumber Indenmitee's right to indemnification under the Charter, the Bylaws, the MGCL or otherwise as applied to any act or failure to act occurring in whole or in part prior to the date upon which the amendment was approved by the Company's Board of Directors and/or its stockholders, as the case may be.

  • Licensed Product The term “Licensed Product” shall mean any product (a) the manufacture, use, importation, sale or offer for sale of which would, in the absence of the license granted by this Agreement, infringe a Valid Claim of any of the Licensed Patent Rights, or (b) that is comprised of, utilizes or incorporates Licensed Biological Materials, or (c) that is discovered, developed or made using a Licensed Process.

  • For clarity the time allowances provided in clause 2.10 shall operate to reduce the maximum timetabled classroom teaching time specified in clause 4.2 of this agreement.

  • Non-Exclusive License Sponsor grants Institution and Principal Investigator a royalty free non-exclusive license, with no right to sublicense, to use Trial Data for internal research or educational purposes.